Uždaroji akcinė bendrovė "CHEMI PHARM GROUP" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
606,658 |
101,110 |
27,732 |
19,728 |
3,288 |
34.76 |
3.25 |
311,671 |
26,284 |
30,403 |
307,552 |
2023 |
---|
598,399 |
99,733 |
52,801 |
44,195 |
7,366 |
33.57 |
7.39 |
300,441 |
39,937 |
24,216 |
316,162 |
2024 |
---|
739,711 |
123,285 |
30,670 |
21,311 |
3,552 |
32.17 |
2.88 |
255,936 |
29,860 |
20,103 |
265,693 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
739,711 €24 % *
Sales per employee (€)
123,285 €24 % *
Profit before tax (€)
30,670 €-42 % *
Net Profit (€)
21,311 €-52 % *
Profit per employee (€)
3,552 €-52 % *
Total profitability (%)
32.17 %-4.17 % *
Net profitability (%)
2.88 %-61.03 % *
Equity (€)
255,936 €-15 % *
Amounts Payable And Liabilities (€)
29,860 €-25 % *
Non-current Assets (€)
20,103 €-17 % *
CurrentAssets (€)
265,693 €-16 % *